OXCARBAZEPINE Side Effects

6583405-2 | Convulsion
on Feb 12, 2010 Female patient from UNITED STATES , weighting 267.4 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Oxcarbazepine dosage: 300 Mg Tabs 3 Qam 3 Qpm Po.

6566717-8 | Stevens-johnson Syndrome
Patient was taking Oxcarbazepine (View Usage). Patient had the following side effects: stevens-johnson syndrome on Jan 13, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , 53 years of age, was diagnosed with convulsion and. Oxcarbazepine dosage: . During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

6552082-9 | Blood Amylase Increased, Hepatitis Cholestatic, Lipase Increased, Liver Injury
Adverse event was reported on Jan 05, 2010 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: ) was diagnosed with partial seizures and. Location: UNITED STATES , 45 years of age, After Oxcarbazepine was administered, patient had the following side effects: blood amylase increased, hepatitis cholestatic, lipase increased, liver injury. Patient was hospitalized.

6550450-2 | Convulsion, Product Substitution Issue
on Jan 22, 2010 Male patient from UNITED STATES , weighting 111.1 lb, was diagnosed with convulsion and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, product substitution issue. Oxcarbazepine dosage: 450 Mg Bid Po.


6544253-2 | Grand Mal Convulsion, Product Substitution Issue
on Jan 19, 2010 Female patient from UNITED STATES , 17 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: grand mal convulsion, product substitution issue. Oxcarbazepine dosage: .

6526466-9 | Blood Amylase Increased, Hepatitis Cholestatic, Lipase Increased
Patient was taking Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: blood amylase increased, hepatitis cholestatic, lipase increased on Dec 15, 2009 from UNITED STATES Additional patient health information: Female patient , 45 years of age, was diagnosed with partial seizures and. Oxcarbazepine dosage: . During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ). Patient was hospitalized.

6522100-2 | Hyponatraemia, Mania
Adverse event was reported on Dec 29, 2009 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: 600 Mg Q Am + 1800 Mg Qhs) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , weighting 134.9 lb, Patient experienced the following unwanted or unexpected effects: hyponatraemia, mania. During the same period patient was treated with ZIPRASIDONE HCL (View Ziprasidone Hcl Review and Ziprasidone Hcl Label ), JUNEL FE (View Junel Fe Review and Junel Fe Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), METFORMIN (View Metformin Review and Metformin Label ), ESOMEPRAZOLE SODIUM (NEXIUM) (View Esomeprazole Sodium (nexium) Review and Esomeprazole Sodium (nexium) Label ). Patient was hospitalized.

6504769-1 | Asthenia, Blood Amylase Increased, Decreased Appetite, Fatigue, Hepatitis Cholestatic, Lipase Increased, Pruritus, Weight Decreased
on Dec 02, 2009 Female patient from UNITED STATES , 45 years of age, was diagnosed with partial seizures and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: asthenia, blood amylase increased, decreased appetite, fatigue, hepatitis cholestatic, lipase increased, pruritus, weight decreased. Oxcarbazepine dosage: . During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ). Patient was hospitalized.

6501935-6 | International Normalised Ratio Decreased
on Dec 02, 2009 Male patient from TURKEY , 16 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: international normalised ratio decreased. Oxcarbazepine dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6496717-8 | Granulocytopenia
Patient was taking Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: granulocytopenia on Nov 30, 2009 from UNITED STATES Additional patient health information: Male patient , 34 years of age, . Oxcarbazepine dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PERPHENAZINE (View Perphenazine Review and Perphenazine Label ).

6483266-6 | International Normalised Ratio Decreased
Adverse event was reported on Dec 08, 2009 by a Male patient taking Oxcarbazepine (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?), international normalised ratio decreased and. Location: , 16 years of age, Patient had the following side effects: international normalised ratio decreased. During the same period patient was treated with WARFARIN SODIUM (10 Mg) (View Warfarin Sodium Review and Warfarin Sodium Label ), CLOPIDOGREL (75 Mg) (View Clopidogrel Review and Clopidogrel Label ), ASPIRIN (300 Mg) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6476650-8 | Hepatitis, Pancreatic Enzymes Increased
on Dec 02, 2009 Female patient from , 45 years of age, was diagnosed with partial seizures and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: hepatitis (What is hepatitis?), pancreatic enzymes increased. Oxcarbazepine dosage: . During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ). Patient was hospitalized.

6476378-4 | Blood Amylase Increased, Hepatitis Acute, Lipase Increased
on Nov 24, 2009 Female patient from UNITED STATES , 45 years of age, weighting 8.07 lb, was diagnosed with partial seizures and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: blood amylase increased, hepatitis acute, lipase increased. Oxcarbazepine dosage: Unk. Patient was hospitalized.

6466230-2 | International Normalised Ratio Decreased
Patient was taking Oxcarbazepine (View Usage). Patient had the following side effects: international normalised ratio decreased on Nov 19, 2009 from TURKEY Additional patient health information: Male patient , 16 years of age, was diagnosed with epilepsy (What is epilepsy?), international normalised ratio decreased and. Oxcarbazepine dosage: . During the same period patient was treated with WARFARIN SODIUM (10 Mg, Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ).

6465978-3 | Blood Amylase Increased, Hepatitis Acute, Lipase Increased, Weight Decreased
Adverse event was reported on Nov 20, 2009 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: Unk) was diagnosed with partial seizures and. Location: UNITED STATES , 45 years of age, weighting 8.07 lb, After Oxcarbazepine was administered, patient had the following side effects: blood amylase increased, hepatitis acute, lipase increased, weight decreased. Patient was hospitalized.

6464367-5 | Aphasia, Aura, Complex Partial Seizures, Emotional Disorder, Gait Disturbance, Impaired Driving Ability, Impaired Work Ability, Mental Impairment, Nausea
on Nov 30, 2009 Female patient from UNITED STATES , 51 years of age, weighting 138.0 lb, was diagnosed with complex partial seizures and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), aura, complex partial seizures, emotional disorder, gait disturbance, impaired driving ability, impaired work ability, mental impairment, nausea (What is nausea?). Oxcarbazepine dosage: 300mg Every 12 Hrs Po. During the same period patient was treated with LEVETIRACETAM (500mg Every 12 Hrs Po) (View Levetiracetam Review and Levetiracetam Label ).

6459090-7 | Fall, Fractured Coccyx, Inappropriate Antidiuretic Hormone Secretion
on Nov 25, 2009 Female patient from UNITED STATES , 56 years of age, weighting 189.6 lb, was diagnosed with convulsion and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: fall (What is fall?), fractured coccyx, inappropriate antidiuretic hormone secretion. Oxcarbazepine dosage: 600 Mg Bid Po. Patient was hospitalized.

6448782-1 | Memory Impairment, Restlessness
Patient was taking Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: memory impairment, restlessness on Nov 09, 2009 from UNITED STATES Additional patient health information: Female patient , 53 years of age, . Oxcarbazepine dosage: . During the same period patient was treated with PREGABALIN (View Pregabalin Review and Pregabalin Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ).

6445712-3 | Fall, Fractured Coccyx, Inappropriate Antidiuretic Hormone Secretion
Adverse event was reported on Nov 18, 2009 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: 600 Mg Bid Po) was diagnosed with convulsion and. Location: UNITED STATES , 56 years of age, weighting 189.6 lb, Patient experienced the following unwanted or unexpected effects: fall (What is fall?), fractured coccyx, inappropriate antidiuretic hormone secretion. Patient was hospitalized.

6443811-3 | Abnormal Behaviour, Condition Aggravated, Stress, Tension, Tic
on Nov 04, 2009 Male patient from UNITED STATES , 16 years of age, was treated with Oxcarbazepine (View Usage). Patient had the following side effects: abnormal behaviour, condition aggravated, stress (What is stress?), tension, tic (What is tic?). Oxcarbazepine dosage: .

6429594-1 | Anaemia, Coeliac Disease, Gastrointestinal Inflammation, Haematochezia
on Oct 23, 2009 Male patient from UNITED STATES , 20 years of age, was diagnosed with abnormal behaviour and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: anaemia, coeliac disease, gastrointestinal inflammation, haematochezia. Oxcarbazepine dosage: 2 Tab; Bid; Po. During the same period patient was treated with RISPERIDONE (0.5 Mg; Bid; Po) (View Risperidone Review and Risperidone Label ), TOPAMAX (Po) (View Topamax Review and Topamax Label ).

6427528-7 | Diabetic Ketoacidosis, Hyperglycaemia, Insulin Resistant Diabetes, Prostate Cancer, Surgery
Patient was taking Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: diabetic ketoacidosis, hyperglycaemia, insulin resistant diabetes, prostate cancer (What is prostate cancer?), surgery (What is surgery?) on Oct 26, 2009 from UNITED STATES Additional patient health information: Male patient , 51 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Oxcarbazepine dosage: 900 Mg, Qd. During the same period patient was treated with INSULIN (300 Units Qd) (View Insulin Review and Insulin Label ), EFFEXOR XR (37.5 Mg, Unk) (View Effexor Xr Review and Effexor Xr Label ).

6421947-0 | Convulsion, Rash
Adverse event was reported on Oct 29, 2009 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: 300mg (2 1/2,3)) . Location: UNITED STATES , 18 years of age, Patient had the following side effects: convulsion, rash (What is rash?).

6421696-9 | Dizziness, Headache, Product Substitution Issue
on Oct 29, 2009 Female patient from UNITED STATES , weighting 149.3 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), product substitution issue. Oxcarbazepine dosage: 300 Mg Tabs 1 - 1/2 Qam 2 Qhs P.o..

6421690-8 | Aura, Product Quality Issue
on Oct 29, 2009 Male patient from UNITED STATES , weighting 144.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: aura, product quality issue. Oxcarbazepine dosage: 300 Mg Tabs 3 Qam 3 Qpm P.o..

6420577-4 | Anaemia, Gastrointestinal Inflammation, Haematochezia
Patient was taking Oxcarbazepine (View Usage). Patient had the following side effects: anaemia, gastrointestinal inflammation, haematochezia on Oct 12, 2009 from UNITED STATES Additional patient health information: Male patient , 20 years of age, was diagnosed with abnormal behaviour and. Oxcarbazepine dosage: 2 Tab;bid;po. During the same period patient was treated with RISPERIDONE (0.5 Mg;bid;po) (View Risperidone Review and Risperidone Label ), TOPAMAX (Po) (View Topamax Review and Topamax Label ).

6412627-6 | Congenital Anomaly, Congenital Jaw Malformation, Dysmorphism, Low Set Ears, Microtia, Postmature Baby
Adverse event was reported on Oct 13, 2009 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: Maternal Dose: 150 Mg/day) was diagnosed with epilepsy (What is epilepsy?) and. Location: FRANCE , weighting 7.67 lb, After Oxcarbazepine was administered, patient had the following side effects: congenital anomaly, congenital jaw malformation, dysmorphism, low set ears, microtia, postmature baby.

6409731-5 | Abnormal Behaviour, Anger, Circadian Rhythm Sleep Disorder, Communication Disorder, Convulsion, Delusion Of Grandeur, Grandiosity, Hallucination, Auditory, Inappropriate Affect
on Oct 09, 2009 Male patient from INDIA , 14 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, anger, circadian rhythm sleep disorder, communication disorder, convulsion, delusion of grandeur, grandiosity, hallucination, auditory, inappropriate affect. Oxcarbazepine dosage: 600 Mg, Unk.

6397608-3 | Asthenia, Confusional State, Dizziness, Gait Disturbance, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion, Stupor, Vomiting
on Sep 28, 2009 Male patient from ITALY , 79 years of age, was treated with Oxcarbazepine (View Usage). Patient had the following side effects: asthenia, confusional state, dizziness (What is dizziness?), gait disturbance, hyponatraemia, inappropriate antidiuretic hormone secretion, stupor, vomiting. Oxcarbazepine dosage: Unk. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LEVETIRACETAM (Unk) (View Levetiracetam Review and Levetiracetam Label ). Patient was hospitalized.

6391105-7 | Paraesthesia, Partial Seizures, Product Substitution Issue
Patient was taking Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: paraesthesia, partial seizures, product substitution issue on Oct 06, 2009 from UNITED STATES Additional patient health information: Female patient , 54 years of age, weighting 130.0 lb, . Oxcarbazepine dosage: 300mg 2tabs Bid Po.

6390746-0 | Blood Pressure Increased, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
Adverse event was reported on Oct 02, 2009 by a Male patient taking Oxcarbazepine (View Usage) (Dosage: ) . Location: , 79 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure increased, hyponatraemia, inappropriate antidiuretic hormone secretion. During the same period patient was treated with SULPIRIDE (View Sulpiride Review and Sulpiride Label ), TETRAZEPAM (View Tetrazepam Review and Tetrazepam Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), FORMOTEROL FUMARATE (View Formoterol Fumarate Review and Formoterol Fumarate Label ), DEXKETOPROFEN (View Dexketoprofen Review and Dexketoprofen Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

6386885-0 | Convulsion, Product Substitution Issue
on Oct 01, 2009 Female patient from UNITED STATES , weighting 116.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: convulsion, product substitution issue. Oxcarbazepine dosage: 300 Mg Tabs 2 Qam 2 Qhs Po.

6386884-9 | Dizziness, Headache, Product Substitution Issue
on Oct 01, 2009 Female patient from UNITED STATES , weighting 136.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), product substitution issue. Oxcarbazepine dosage: 300 Mg Tabs 1 1/2 Qam 2 Qhs P.o..

6383560-3 | Ammonia Increased, Grand Mal Convulsion, Hyponatraemia, Treatment Noncompliance
Patient was taking Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: ammonia increased, grand mal convulsion, hyponatraemia, treatment noncompliance on Sep 29, 2009 from UNITED STATES Additional patient health information: Male patient , 54 years of age, weighting 194.0 lb, was diagnosed with convulsion and. Oxcarbazepine dosage: 600 Mg Bid Po. During the same period patient was treated with VALPROIC ACID (500 Mg Bid Po) (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

6379767-1 | Convulsion, Dizziness, Heart Rate Increased, Product Substitution Issue, Tinnitus, Vision Blurred
Adverse event was reported on Sep 23, 2009 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: 45 Mg 1/daily (am) Oral; 375/mg 1/daily (pm) Oral) was diagnosed with epilepsy (What is epilepsy?) and. Location: UNITED STATES , weighting 95.00 lb, Patient had the following side effects: convulsion, dizziness (What is dizziness?), heart rate increased, product substitution issue, tinnitus (What is tinnitus?), vision blurred.

6379035-8 | Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion, Malaise
on Sep 22, 2009 Male patient from UNITED KINGDOM , 44 years of age, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: hyponatraemia, inappropriate antidiuretic hormone secretion, malaise. Oxcarbazepine dosage: 450 Mg, Bid.

6376779-9 | Convulsion, Product Substitution Issue
on Sep 24, 2009 Female patient from UNITED STATES , weighting 116.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, product substitution issue. Oxcarbazepine dosage: 300mg Tabs 2qam; 3 Qhs P.o..

6375785-8 | Economic Problem, Product Quality Issue, Product Substitution Issue
Patient was taking Oxcarbazepine (View Usage). Patient had the following side effects: economic problem, product quality issue, product substitution issue on Sep 22, 2009 from UNITED STATES Additional patient health information: Male patient , 37 years of age, weighting 223.0 lb, was diagnosed with head injury, sleep disorder (What is sleep disorder?) and. Oxcarbazepine dosage: 600 Mg 3@ Bed Po. During the same period patient was treated with TRILEPTAL (View Trileptal Review and Trileptal Label ).

6369126-X | Convulsion, Product Substitution Issue
Adverse event was reported on Sep 17, 2009 by a Female patient taking Oxcarbazepine (View Usage) (Dosage: 450 Mg 1/daily -am- Po; 375 Mg 1/daily -pm- Po) was diagnosed with epilepsy (What is epilepsy?) and. Location: UNITED STATES , weighting 95.00 lb, After Oxcarbazepine was administered, patient had the following side effects: convulsion, product substitution issue.

6362060-0 | Conjunctival Hyperaemia, Convulsion, Electroencephalogram Abnormal, Nuclear Magnetic Resonance Imaging Brain Abnormal
on Sep 15, 2009 Male patient from BRAZIL , 15 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival hyperaemia, convulsion, electroencephalogram abnormal, nuclear magnetic resonance imaging brain abnormal. Oxcarbazepine dosage: Unk. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ).

6356052-5 | Convulsion, Product Substitution Issue
on Sep 10, 2009 Female patient from UNITED STATES , weighting 137.8 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: convulsion, product substitution issue. Oxcarbazepine dosage: 600mc Bid P.o..

6342225-4 | Convulsion, Diplopia, Eye Pain, Headache, Product Substitution Issue
Patient was taking Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: convulsion, diplopia, eye pain, headache (What is headache?), product substitution issue on Sep 03, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 231.5 lb, was diagnosed with epilepsy (What is epilepsy?) and. Oxcarbazepine dosage: 600 Mg Tabs 1 Qam 2 Qhs P.o..

6342169-8 | Convulsion, Diplopia, Eye Pain, Headache, Product Substitution Issue
Adverse event was reported on Sep 03, 2009 by a Male patient taking Oxcarbazepine (View Usage) (Dosage: 600 Mg Tabs 1 Qam 2 Qhs Po) was diagnosed with epilepsy (What is epilepsy?) and. Location: UNITED STATES , weighting 231.5 lb, Patient experienced the following unwanted or unexpected effects: convulsion, diplopia, eye pain, headache (What is headache?), product substitution issue.

6342119-4 | Hypersomnia, Somnolence
on Sep 03, 2009 Female patient from UNITED STATES , 13 years of age, was diagnosed with convulsion and was treated with Oxcarbazepine (View Usage). Patient had the following side effects: hypersomnia, somnolence. Oxcarbazepine dosage: 600 Mg 2x/day Po.

6342089-9 | Condition Aggravated, Migraine, Product Substitution Issue
on Sep 03, 2009 Male patient from UNITED STATES , weighting 134.9 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: condition aggravated, migraine (What is migraine?), product substitution issue. Oxcarbazepine dosage: 500mg Tabs 1 Tab Q Am 1-1/2 Qhs P.o..

6341300-8 | Headache, Hypertension, Hyponatraemia
Patient was taking Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), hypertension, hyponatraemia on Sep 02, 2009 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 125.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Oxcarbazepine dosage: 1200mg Bid Po. During the same period patient was treated with TRIAMTERENE AND HYDROCHLOROTHIAZIDE (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), CATAPRES TTS 3 (View Catapres-tts-3 Review and Catapres-tts-3 Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ).

6337386-7 | Depression, Stress
Adverse event was reported on Sep 01, 2009 by a Male patient taking Oxcarbazepine (View Usage) (Dosage: 600 Mg Bid Po) . Location: UNITED STATES , 57 years of age, weighting 185.0 lb, Patient had the following side effects: depression (What is depression?), stress (What is stress?). During the same period patient was treated with CLONAZEPAM (1 Mg Qid Po) (View Clonazepam Review and Clonazepam Label ).

6337368-5 | Alopecia
on Sep 01, 2009 Female patient from UNITED STATES , weighting 274.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Oxcarbazepine (View Usage). After Oxcarbazepine was administered, patient had the following side effects: alopecia. Oxcarbazepine dosage: 300mg Once Bid - Twice Bid Oral.

6336632-3 | Dizziness, Gait Disturbance, Headache, Hyperhidrosis, Nausea, Visual Impairment
on Aug 31, 2009 Female patient from UNITED STATES , 41 years of age, weighting 115.0 lb, was diagnosed with complex partial seizures and was treated with Oxcarbazepine (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), gait disturbance, headache (What is headache?), hyperhidrosis, nausea (What is nausea?), visual impairment. Oxcarbazepine dosage: 150 Mg Twice A Day Po. During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ).

6333273-9 | Conjunctivitis, Epilepsy, Stevens-johnson Syndrome
Patient was taking Oxcarbazepine (View Usage). Patient had the following side effects: conjunctivitis, epilepsy (What is epilepsy?), stevens-johnson syndrome on Aug 24, 2009 from Additional patient health information: Male patient , 53 years of age, was diagnosed with epilepsy (What is epilepsy?), convulsion and. Oxcarbazepine dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.